Peripheral

Six-month outcomes of a randomized trial of renal denervation versus a sham procedure for resistant hypertension—impact of treatment-blinded medicat...

Evaluating whether drug-coated devices (DCDs) used for femoropopliteal artery revascularization are non-inferior to non-drug-coated devices (NDCDs) ...

The coronavirus disease 2019 (COVID-19) pandemic has impacted many aspects of ST-segment elevation myocardial infarction (STEMI) care, including tim...

This is an interim analysis of the prospective multicenter US registry examining efficacy and safety of the catheter embolectomy with Flow Triever S...

Long-term Safety of Drug-Coated Devices in Peripheral Artery Revascularization

4-Year ILLUMENATE Global Stellarex DCB Data

A Randomzied Trial of Drug-Coated Balloon Angioplasty in the Infrapopliteal Arteries

Acute Hemodynamic Improvement With Percutaneous Mechanical Thrombectomy in a Real-World Pulmonary Embolism Population

If approved by the FDA, this device will join two others designed specifically for use in the veins. From tctMD.com

The Society for Cardiovascular Angiography and Interventions released guidelines on selection of devices for aortoiliac arterial interventions. Fro...